Product Information
VENLAFAXINE HCL 37.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0795 per EA under NDC 00093914801. Its NADAC has been published 315 times since Jun 17, 2020.
Strength
37.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093914801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076690On Market Since
8/4/2006
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 37.5 MG TABLET has been published 315 times since Jun 17, 2020, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0795 per EA |
|---|---|
| All-time high | $0.1354 (Jun 16, 2021) |
| All-time low | $0.0609 (May 22, 2024) |
| 52-week high | $0.0822 |
| 52-week low | $0.0728 |
| Median price | $0.0822 |
| Average price | $0.0896 |
| Largest weekly change | +58.7% (Jun 19, 2024) |
| Weeks tracked | 315 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 37.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0795 per EA (NDC 00093914801), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has declined 35.2%. It has been tracked across 315 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 37.5 MG TABLET?
Since Jun 17, 2020, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has ranged from a low of $0.0609 (May 22, 2024) to a high of $0.1354 (Jun 16, 2021), with a median of $0.0822 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 37.5 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 37.5 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 37.5 MG TABLET?
VENLAFAXINE HCL 37.5 MG TABLET (NDC 00093914801) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification